about
Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathyThe molecular basis for cyclopiazonic acid inhibition of the sarcoplasmic reticulum calcium pumpMacrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype.Phospholamban C-terminal residues are critical determinants of the structure and function of the calcium ATPase regulatory complex.Mechanism of action of the novel aminomethylcycline antibiotic omadacycline.Regulation of the sarcoplasmic reticulum calcium pump by divergent phospholamban isoforms in zebrafish.Transmembrane helix 11 is a genuine regulator of the endoplasmic reticulum Ca2+ pump and acts as a functional parallel of β-subunit on α-Na+,K+-ATPase.Deception in simplicity: hereditary phospholamban mutations in dilated cardiomyopathy.Engineering a novel iron-sulfur cluster into the catalytic subunit of Escherichia coli dimethyl-sulfoxide reductase.Organization of dimethyl sulfoxide reductase in the plasma membrane of Escherichia coli.The tetracycline resistance protein Tet(o) perturbs the conformation of the ribosomal decoding centre.The effects of mutation on the regulatory properties of phospholamban in co-reconstituted membranes.Peptide inhibitors use two related mechanisms to alter the apparent calcium affinity of the sarcoplasmic reticulum calcium pump.Ribosomal protection from tetracycline mediated by Tet(O): Tet(O) interaction with ribosomes is GTP-dependent.Rational design of peptide inhibitors of the sarcoplasmic reticulum calcium pumpBinding of the periplakin linker requires vimentin acidic residues D176 and E187
P50
Q24307897-35DA25C2-5076-47E9-B0D4-0B6321E79309Q27643680-0162B985-E9F2-4D2C-A7E4-6E91E24C703EQ33883691-DBA5CCCF-EFB1-4EDD-ACB6-5CD0C1513252Q34170810-C79A74C6-4860-432E-BFCA-07761D667FB4Q34371620-BC8687B8-D635-49B9-818E-9D4A8B3AAF19Q35172596-3B9BD58C-77AF-41AC-889A-57DF4CFBF18CQ36016768-91E82AC3-B0F5-498E-A3CC-0F61679A7960Q38309119-DC01C89D-1B20-4307-BD3D-B7915762B473Q38361228-BE664A5D-ED9E-4274-B68A-B66FA81EE3F2Q40343904-638719CE-E221-4394-93B1-55B3E8CDDBE5Q44158520-2F217072-EC59-436C-AED9-EBF530595E4BQ45286891-CE7214E2-2D3E-41D6-BDB3-AC9A0BDE2F1EQ46430308-8FE73789-5F84-448E-AD9B-0356EB1C6DC2Q47683708-45D4F7A5-6F2B-4619-8FEF-A3F2A9CE49B3Q79882349-6B32DB0B-3EAF-4F66-8D54-31DEB1393F67Q89819060-9BDA0076-E1E9-4483-93E8-455B1FF08DAE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Catharine A Trieber
@ast
Catharine A Trieber
@en
Catharine A Trieber
@es
Catharine A Trieber
@nl
type
label
Catharine A Trieber
@ast
Catharine A Trieber
@en
Catharine A Trieber
@es
Catharine A Trieber
@nl
prefLabel
Catharine A Trieber
@ast
Catharine A Trieber
@en
Catharine A Trieber
@es
Catharine A Trieber
@nl
P106
P31
P496
0000-0002-1336-1126